EGFR kinase inhibitor 7

Ref. TM-T89895

Produktinformation

• Name: EGFR kinase inhibitor 7
• Marke: Targetmol
• Beschreibung: EGFRkinase inhibitor 7 (compound 18i) is an EGFR inhibitor with an IC50 of 42.3 nM, exhibiting anticancer properties. This compound demonstrates significant in vitro cytotoxicity and capacity to induce apoptosis. Furthermore, EGFRkinase inhibitor 7 displays anti-proliferative activity against human colon cancer cell line HCT116 and human non-small cell lung cancer cell line A549, with IC50 values of 4.82 µM and 1.43 µM, respectively.

Chemische Eigenschaften

• Molekulargewicht: 653.45
• Formel: C₂₈H₂₆Cl₂FN₃O₃SSe
• Farbe/Form: Solid